12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
- Pulmonx (NASDAQ:LUNG) shares rose 29.5% to $10.0 during Wednesday's after-market session. The market value of their outstanding shares is at $388.1 million. The company's, Q1 earnings came out today.
- Butterfly Network (NYSE:BFLY) shares moved upwards by 18.15% to $0.93. The company's market cap stands at $193.5 million. As per the press release, Q1 earnings came out today.
- Compass Therapeutics (NASDAQ:CMPX) stock rose 11.46% to $1.75. The market value of their outstanding shares is at $240.7 million.
- Sharps Technology (NASDAQ:STSS) shares increased by 9.2% to $0.27. The market value of their outstanding shares is at $4.2 million.
- Blueprint Medicines (NASDAQ:BPMC) shares moved upwards by 6.47% to $101.0. The market value of their outstanding shares is at $6.3 billion.
- Asensus Surgical (AMEX:ASXC) stock rose 6.32% to $0.25. The market value of their outstanding shares is at $69.0 million.
Losers
- Envista Holdings (NYSE:NVST) stock decreased by 12.5% to $17.29 during Wednesday's after-market session. The company's market cap stands at $2.9 billion. As per the press release, Q1 earnings came out today.
- Accuray (NASDAQ:ARAY) shares declined by 12.45% to $1.9. The market value of their outstanding shares is at $188.4 million. As per the news, the Q3 earnings report came out today.
- Allakos (NASDAQ:ALLK) stock declined by 9.74% to $1.02. The market value of their outstanding shares is at $90.3 million.
- Psyence Biomedical (NASDAQ:PBM) shares decreased by 7.5% to $1.11. The market value of their outstanding shares is at $14.8 million.
- Schrodinger (NASDAQ:SDGR) stock fell 7.37% to $23.4. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out today.
- Indaptus Therapeutics (NASDAQ:INDP) stock fell 6.94% to $1.88. The company's market cap stands at $16.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.